We are pleased to announce the 3rd edition of the MAP meeting; a joint initiative of ESMO, UNICANCER and Cancer Research UK. MAP will continue to explore and discuss the clinical interpretation of molecular analysis for metastatic cancers alongside medical oncologists, researchers, onco-geneticians, clinical investigators, molecular biologists, cytopathologists, radiotherapists, fellows, academics, regulators and industry R&D.
Young Oncologist Grants: Young oncologists under 40 years old who present an abstract are eligible to apply for a travel grant.
Accepted abstracts will be published in the Annals of Oncology journal.
The EACR is grateful for the continued support of its Industry Partners: